-
/339344/develop-flow-cytometry-hardware-to-c… Contact City Amsterdam Zuidoost Website https://www.amsterdamumc.org/ Street Meibergdreef 9 Postal Code 1105 AZ STATUS: EXPIRED
-
, in parallel, explore CRISPR and AAV technologies to develop new ocular gene therapy. We have all multidisciplinary facilities, technology and expertise needed directly at our disposal. The candidate
-
develop solutions for the current diabetes pandemic. Within the project, we will closely collaborate with a second PhD student and a clinician located at Maastricht University and Maastricht UMC+, who will
-
under control and MS relevant inflammatory conditions. You will: Further develop white and grey matter stem cell co-cultures; Develop and perform experiments to address the research questions formulated
-
Alzheimer’s disease such as ApoE4. In this PhD project, you will apply this previous knowledge to develop cellular screening assays in order to identify novel candidate interventions for Alzheimer’s disease
-
. About the role You will first be stationed for 1.5 years at the Vrije Universiteit in Amsterdam to develop a set of tools to assess listening value in real-life occupational settings through self-report
-
the laboratory of Genetic Metabolic Diseases. Conduct cutting-edge research in molecular therapy, focusing on technologies such as AAV, RNA therapeutics, and CRISPR/Cas. Develop and implement strategies to secure
-
or carried out their main activity (work, studies, etc.) in the Netherlands for more than 12 months in the 3 years immediately before the recruitment date. Your education has to correspond to a four- to five
-
. Additional Information Benefits One-year contract with the prospect of a permanent contract. Classification in salary scale 8b: € 3.270 - € 4.631 Gross for full-time employment (depending on education and
-
receptor types, how this determines immunity, and develop novel tools to block pathogen binding to CLRs and Siglec receptors. For this you will isolate, produce and characterize nanobodies that can bind CLRs